Pathogenic variants in CHEK2 have not been traditionally linked to renal cell carcinoma, but they were the most prevalent germline alteration (3.5%) in a study of 254 advanced renal cell carcinomas (28). This evidence concerns the gene CHEK2 and renal cell carcinoma.